Screening and validation of prognostic indicator genes in the progression of HBV related hepatocellular carcinoma

Jinglin Wang , Senzhe Xia , Yuyan Chen , Xueqian Qin , Shujun Liu , Haozhen Ren
{"title":"Screening and validation of prognostic indicator genes in the progression of HBV related hepatocellular carcinoma","authors":"Jinglin Wang ,&nbsp;Senzhe Xia ,&nbsp;Yuyan Chen ,&nbsp;Xueqian Qin ,&nbsp;Shujun Liu ,&nbsp;Haozhen Ren","doi":"10.1016/j.bmt.2022.10.002","DOIUrl":null,"url":null,"abstract":"<div><p>Hepatocellular carcinoma (HCC) is a rapidly progressing cancer and the main reason for cancer-related deaths. There are numerous risk factors for HCC, of which hepatitis B virus (HBV) infection is recognized as a high risk. HBV infection is accompanied by gene integration, and the liver has undergone the process of continuous and repeated damage and repair. However, predictive factors of HBV-related HCC are still limited, and the prognostic regulatory genes have not been fully elucidated. This study aims to use bioinformatics analysis to search potential prognostic genes of HBV-related HCC. Based on the full utilization of the GEO database, we screened out prognostic-related genes by performing systematic Kaplan-Meier survival analysis. The differences of the transcriptional information and protein expression were verified in the TCGA and HPA databases respectively, and the clinical characteristics of the screened genes were described by the boxplot. Five prognostic-related genes we screened, including CDK1, MAD2L1, SPP1, TYMS, and CCNA2, are strongly linked with poor prognosis in HBV-related HCC. The five prognostic-related genes have realistic clinical significance and potential as prognostic markers, and may provide new directions for basic research and clinical diagnosis.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"1 ","pages":"Pages 10-17"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949723X22000022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Hepatocellular carcinoma (HCC) is a rapidly progressing cancer and the main reason for cancer-related deaths. There are numerous risk factors for HCC, of which hepatitis B virus (HBV) infection is recognized as a high risk. HBV infection is accompanied by gene integration, and the liver has undergone the process of continuous and repeated damage and repair. However, predictive factors of HBV-related HCC are still limited, and the prognostic regulatory genes have not been fully elucidated. This study aims to use bioinformatics analysis to search potential prognostic genes of HBV-related HCC. Based on the full utilization of the GEO database, we screened out prognostic-related genes by performing systematic Kaplan-Meier survival analysis. The differences of the transcriptional information and protein expression were verified in the TCGA and HPA databases respectively, and the clinical characteristics of the screened genes were described by the boxplot. Five prognostic-related genes we screened, including CDK1, MAD2L1, SPP1, TYMS, and CCNA2, are strongly linked with poor prognosis in HBV-related HCC. The five prognostic-related genes have realistic clinical significance and potential as prognostic markers, and may provide new directions for basic research and clinical diagnosis.

HBV相关肝细胞癌进展中预后指示基因的筛选和验证
肝细胞癌(HCC)是一种进展迅速的癌症,也是导致癌症相关死亡的主要原因。HCC有许多危险因素,其中乙型肝炎病毒(HBV)感染被认为是高危因素。HBV感染伴随着基因整合,肝脏经历了不断重复的损伤和修复过程。然而,HBV相关HCC的预测因素仍然有限,预后调控基因尚未完全阐明。本研究旨在利用生物信息学分析来寻找HBV相关HCC的潜在预后基因。在充分利用GEO数据库的基础上,我们通过系统的Kaplan-Meier生存分析筛选出预后相关基因。在TCGA和HPA数据库中分别验证了转录信息和蛋白质表达的差异,并用盒图描述了筛选基因的临床特征。我们筛选的五个预后相关基因,包括CDK1、MAD2L1、SPP1、TYMS和CCNA2,与HBV相关HCC的不良预后密切相关。这五个预后相关基因作为预后标志物具有现实的临床意义和潜力,可能为基础研究和临床诊断提供新的方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信